Alix Marduel Corcept Therapeutics Inc
As of November 13, 2008
Alix Marduel Net Worth
- Net worth is estimated to be at least $84.23M
- Owns at least 166,491 units of Corcept Therapeutics Inc stock
Alix Marduel Trading
- Largest purchase of shares was 1,059,135 units , worth over $2.93M on March 26, 2008
- In total has made about 7 transactions over 4 years
- Usually trades in August and April, with the busiest year in 2007
ALTA BIOPHARMA PARTNERS II LP, ALIX MARDUEL, JEAN DELEAGE, FARAH CHAMPSI, ALTA BIOPHARMA MANAGEMENT II LLC, ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC, ALTA PARTNERS II INC
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Alix Marduel Mailing Address
- Mailing address is One Embarcadero Center Suite 3700 San Francisco CA 94111 CA
Corcept Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Joseph K. Belanoff, M.D., | 2020 | $769,567 | $744,000 | $4,237,643 | $10,892 | $5,762,102 |
| Joseph K. Belanoff, M.D., | 2019 | $707,525 | $745,290 | $3,506,155 | $ | $4,958,970 |
| Joseph K. Belanoff, M.D., | 2018 | $679,792 | $477,750 | $5,157,075 | $ | $6,314,617 |
| Andreas Grauer, M.D., | 2020 | $454,550 | $219,157 | $1,271,293 | $118,274 | $2,063,274 |
| Andreas Grauer, M.D., | 2019 | $362,267 | $243,720 | $3,115,335 | $78,245 | $3,799,567 |
| Hazel Hunt, Ph.D., | 2020 | $431,873 | $243,000 | $2,084,640 | $ | $2,759,513 |
| Sean Maduck, | 2020 | $474,380 | $214,157 | $2,508,404 | $ | $3,196,941 |
| Sean Maduck, | 2019 | $456,133 | $308,881 | $1,476,276 | $ | $2,241,290 |
| Sean Maduck, | 2018 | $436,667 | $198,000 | $2,171,400 | $ | $2,806,067 |
| Charles Robb, | 2020 | $474,380 | $321,236 | $2,118,822 | $ | $2,914,438 |
| Charles Robb, | 2019 | $456,133 | $308,881 | $1,845,345 | $ | $2,610,359 |
| Charles Robb, | 2018 | $436,667 | $237,600 | $2,171,400 | $ | $2,845,667 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1088856/000162828021007363/a2021def14a.htm
Corcept Therapeutics Inc Insider Trading
- The most recent transaction was 35,000 units sold on May 19, 2022 by Gary Charles worth over $684.4K
- In the last 18 years, insiders at Corcept Therapeutics Inc sold an estimated value of $163.14M and bought an estimated value of $183.48M
- The most active traders are Joseph K Belanoff, Chief Executive Officer, Robert Roe, President and Secretary, and Leonard Baker Jr, Director
- Insider trading is most common in February, with the busiest year in 2006
CORCEPT THERAPEUTICS INC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||